Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4538]

AACR 2017: Avelumab was safe and yielded durable responses for patients with advanced merkel cell carcinoma

AACR 2017: Avelumab was safe and yielded durable responses for patients with advanced merkel cell carcinoma

AACR 2017: Triple-negative breast cancer patients who responded to immunotherapy had long-term survival benefit

AACR 2017: Triple-negative breast cancer patients who responded to immunotherapy had long-term survival benefit

AACR 2017: Combination of nivolumab and ipilimumab improved overall survival for advanced melanoma patients

AACR 2017: Combination of nivolumab and ipilimumab improved overall survival for advanced melanoma patients

AACR 2017: Combination HER2-targeted therapy effective in heavily pretreated HER2 positive colorectal cancer patients

AACR 2017: Combination HER2-targeted therapy effective in heavily pretreated HER2 positive colorectal cancer...

American cancer death rates continue to decline in latest annual report

American cancer death rates continue to decline in latest annual report

Different databases, differing statistics on racial disparities in immediate breast reconstruction after mastectomy

Different databases, differing statistics on racial disparities in immediate breast reconstruction after mastectomy

Link between common prostate cancer treatment, dementia detailed in new study

Link between common prostate cancer treatment, dementia detailed in new study

UAB creates triple-threat cancer-fighting polymer capsules for guided drug delivery

UAB creates triple-threat cancer-fighting polymer capsules for guided drug delivery

Single-cell RNA sequencing reveals detailed composition of two major types of brain tumour

Single-cell RNA sequencing reveals detailed composition of two major types of brain tumour

High doses of vitamin C to improve cancer treatment passes human safety trial

High doses of vitamin C to improve cancer treatment passes human safety trial

More from ecancer